"The bottom is over, the support is good, and the market outlook of Darui Biotech can be expected......" This is the research report given by the Institute of Finance and Economics of Beijing Finance University.

The research report given by Wang Nuo is also very simple, and the title is very clear and clear, just asking: "Do you want us to take over?"

If you want to miss it by one minute, two research reports in a row, from the votes to the arguments, are almost completely overlapping, but the arguments are biased, which is the pertinence.

"Looking at the biomedical sector in the third quarter, it was first hit by the pharmaceutical bribery scandal, and then dragged down by the broader market, and most stocks handed back the gains in the second quarter......"

"From the perspective of the price trend, Darui Biotech has taken an inverted V-shape from the second quarter to the present, and looking at the trend of the second quarter, it can be clearly seen that the L low is about to be finished, the bottom doji appears frequently, and the signs of recoil are obvious......"

"The support of the data surface, the locking of the downside, and the good support in the field of gene sequencing may be able to promote the rise of related stocks......"

Liu Dechuan looked at the public research report of the Beijing Finance Institute with relish, just looking at this document, it is really leaky, from the data side to the fundamentals, the combination of the two, reasonable and well-founded, no one can find fault.

But looking back at Wang Nuo's research report, things become very interesting.

"The biopharmaceutical industry has walked out of the price curve that fits the broader market in the middle line, rising in the second quarter and rising first and then falling in the third quarter, dragged down by the bearishness, and even chose to lead the decline, or because the profit market escaped too much......

"The downside of Darui Biotech is locked, the reason is obvious, the funds are building positions, which can be analyzed from the data of the continuous reduction of the number of shareholders, but whether it is institutional shareholders or natural person shareholders, there is not much change......

"The gene sequencing business is not the main direction of Darui Biotech, accounting for less than 10%, but the meager earnings per share leads to excessive PE and excessive involvement in the information of the pharmaceutical bribery scandal, so that Darui Biotech has room for further decline. ”

"Make a bold guess that if Darui Biotech has funds to build a position at the bottom, the continuous sideways and appropriate amount of energy are enough for the funds to complete the position building work, and after forcibly locking the downside, the next step is naturally to pull up the stage......"

If Liu Dechuan read the research report of the Beijing Finance Research Institute with relish, then the reason is naturally that he felt overjoyed after seeing Wang Nuo's research report.

When Beijing Finance University said that the bottom was over and the upside space was opened, Wang Nuo said that it was an institution that forcibly locked the price and would manipulate the stock price...... Be careful about taking the plate and whether it should be taken or not.

The arguments on both sides are actually similar, but the data and information are roughly the same, mixed with the wishes of different analysts, and it is natural to form a different opinion.

On top of that, the two reports appeared less than a minute apart.

What does this mean?

This means that as soon as the research report of the Beijing Finance University Financial Research Institute emerged, Wang Nuo knocked it down with a stick, fast and accurate, without the slightest deviation.

But it's not a big deal, because of the influence.

Wang Nuo's report is almost not read, the research report of the Beijing Finance Research Institute is the influential information, coupled with the operation of the Hongsheng Fund, if there is no third party to intervene, Darui Biology is likely to walk out of the curve expected by the Beijing Finance Research Institute.

And then...... Hongsheng Fund makes money, Jingcai University Financial Research Institute makes fame, and everyone takes what they need.

Liu Dechuan laughed that he was a third party, or that the Shanghai Finance Institute was a third party, and he had made arrangements just now, presumably Ma Lin was already about to rush up to show a hand.

"Tuk tuk tuk ......" Liu Dechuan was thinking about Ma Lin when there was a quick knock on the office door.

"Professor, I found two very interesting research reports...... Ma Lin has been paying attention to Wang Nuo's movements under Liu Dechuan's intentional or unintentional prompting, and as a person from the Shanghai Finance Research Institute, he has also been reading the research reports of the Beijing Finance Research Institute.

When the two research reports came out, Ma Lin was almost stunned.

With the same arguments, extremely close time, and completely different views, is it possible that the Jingcai University Financial Research Institute has been stolen from the information?

Otherwise, it would be too much of a coincidence.

But right or wrong, Ma Lin is not qualified to care, what he needs to do is to tell Liu Dechuan about the matter, and he also believes that Liu Dechuan and even the Shanghai University of Finance and Economics Financial Research Institute will definitely be interested in this matter.

"Be steady!" Liu Dechuan pretended to reprimand Ma Lin and said, "What kind of report, take a look." ”

"I just printed it out. Ma Lin said cautiously and handed the document to Liu Dechuan.

Liu Dechuan took it and looked at the information slowly, with some small surprised expressions on his face.

In Ma Lin's view, this is the performance of Professor Liu's "Mount Tai collapses in front of him and his face does not change".

What a big deal, Liu Dechuan just showed a "little" surprised expression, not a professor.

"Why are you showing me this?" asked Liu Dechuan.

"I think...... We might be able to repost that. Ma Lin made a suggestion.

"Do you think that the Beijing Finance University will be planted?" Liu Dechuan straightened his face and said: "It is ultimately capital that determines the stock price, and even if the research report is correct, it may not necessarily affect the market." ”

"I know, but ...... We won't have anything to lose, no matter what the outcome is, this research report will be sent out, and it will be enough for the guys in Jingcaida. Ma Lin knows Liu Dechuan's character very well, if the professor didn't agree, he would have been angry a long time ago, how could he still talk about the consequences.

"Well, you go out first, I'll talk to the center. Sure enough, Liu Dechuan waved his hand, and when Ma Lin left, there was still an expression on his face of "Mount Tai collapsed in front of him and his face did not change", but he was as happy as a child getting a toy.

Just like Ma Lin said, there will be no losses anyway, so why not do it? Shanghai Finance University has added to Beijing's financial blockage, and there is no need for any reason or excuse at all.

No matter what the stock price trend is, what Liu Dechuan knows is: Wang Nuo has succeeded.

The research report that has just been released, the arguments that have been used by others as if they are different have been stepped on from beginning to end, and laymen may look at the results and then evaluate the winners, and people in the industry can see at a glance: the face of the Beijing Finance University Financial Research Institute has been swollen.

If Hongsheng's operation is affected as a result...... Then the picture shouldn't be too pretty.

"What I didn't expect was that he actually made the research report. Liu Dechuan remembered this and was excited.